Rheumatoid arthritis, ulcerative colitis, atopic dermatitis, Crohn's disease, psoriatic arthritis, axial spondyloarthritis

2 total trials

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

An open label, balanced, randomized, two-treatment, four period, two-sequence, multiple-dose (steady-state), fully-replicate crossover bioeq … Ended

2024-512770-10-00 2 2024-10-07
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Upadaci … Ended

2024-512773-27-00 2 2024-08-19

Showing 1–2 of 2 trials